Provided by Tiger Fintech (Singapore) Pte. Ltd.

Azitra Inc

0.5699
+0.02554.68%
Post-market: 0.59550.0256+4.49%19:59 EDT
Volume:660.12K
Turnover:383.76K
Market Cap:3.08M
PE:-0.06
High:0.6244
Open:0.5470
Low:0.5467
Close:0.5444
52wk High:4.33
52wk Low:0.5049
Shares:5.40M
Float Shares:5.39M
Volume Ratio:0.03
T/O Rate:12.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.7766
EPS(LYR):-15.7811
ROE:-473.31%
ROA:-180.76%
PB:1.38
PE(LYR):-0.04

Loading ...

Company Profile

Company Name:
Azitra Inc
Exchange:
AMEX
Establishment Date:
2014
Employees:
12
Office Location:
21 Business Park Drive,Branford,Connecticut,United States
Zip Code:
06405
Fax:
- -
Introduction:
Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.

Directors

Name
Position
Francisco D. Salva
President, Chief Executive Officer and Director
Barbara Ryan
Independent Director
John Schroer
Independent Director
Travis Whitfill
Chief Operating Officer and Director

Shareholders

Name
Position
Francisco D. Salva
President, Chief Executive Officer and Director
Travis Whitfill
Chief Operating Officer and Director
Norman Staskey
Chief Financial Officer